News from us and our partners

Tags

Topics

0 results

News
3 October, 2018
Synthace publishes whitepaper on computer-aided biology
News
3 October, 2018
DNA Script reaches 200-nucleotide enzymatic DNA synthesis
News
2 October, 2018
Inotrem announces positive results from the Phase IIa study of its lead compound, nangibotide (LR12), in the treatment of septic shock.
News
12 September, 2018
ProQR Announces Closing of Underwritten Public Offering of Ordinary Shares with Full Exercise of Underwriters’ Option to Purchase Additional Shares
News
18 July, 2018
HotSpot Therapeutics Completes $45 Million Series A Financing to Advance New Approach to Allosteric Drug Discovery
News
11 July, 2018
Breath Therapeutics Appoints Noreen Roth Henig, M.D. as Chief Medical Officer
News
10 July, 2018
Le programme CALYPSO va bénéficier d’une aide de 14 millions d’euros dans le cadre du Programme d’Investissements d’Avenir (PIA) opéré par Bpifrance, afin de développer CorWave Neptune, une assistance
News
10 July, 2018
CorWave’s next-generation LVAD, Neptune, receives funding
News
10 July, 2018
Sofinnova Partners Announces the Sale of ReCor Medical to Otsuka Holdings
News
2 July, 2018
Renewable chemicals naturally designed and engineered to deliver the performance that adds value to everyday products
News
26 June, 2018
NodThera secures £28 million ($40 million) Series A Financing
News
9 June, 2018
Hookipa and Gilead Enter Into A Collaboration And License Agreement To Develop Immunotherapies Against HIV And Hepatitis B
News
1 June, 2018
Zai Lab and Crescendo Biologics Enter Exclusive Worldwide License Agreement for Innovative Protein Therapeutics for Inflammatory Indications
News
22 May, 2018
Sofinnova Partners appoints Dr. Martin T. Rothman as Venture Partner
News
22 May, 2018
Highlife appoints Dr. Martin Rothman as independent member of the board
News
22 May, 2018
Shockwave Launches Coronary Intravascular Lithotripsy in Europe

Synthace publishes whitepaper on computer-aided biology

DNA Script reaches 200-nucleotide enzymatic DNA synthesis

Inotrem announces positive results from the Phase IIa study of its lead compound, nangibotide (LR12), in the treatment of septic shock.

ProQR Announces Closing of Underwritten Public Offering of Ordinary Shares with Full Exercise of Underwriters’ Option to Purchase Additional Shares

HotSpot Therapeutics Completes $45 Million Series A Financing to Advance New Approach to Allosteric Drug Discovery

Breath Therapeutics Appoints Noreen Roth Henig, M.D. as Chief Medical Officer

Le programme CALYPSO va bénéficier d’une aide de 14 millions d’euros dans le cadre du Programme d’Investissements d’Avenir (PIA) opéré par Bpifrance, afin de développer CorWave Neptune, une assistance

CorWave’s next-generation LVAD, Neptune, receives funding

Sofinnova Partners Announces the Sale of ReCor Medical to Otsuka Holdings

Renewable chemicals naturally designed and engineered to deliver the performance that adds value to everyday products

NodThera secures £28 million ($40 million) Series A Financing

Hookipa and Gilead Enter Into A Collaboration And License Agreement To Develop Immunotherapies Against HIV And Hepatitis B

Zai Lab and Crescendo Biologics Enter Exclusive Worldwide License Agreement for Innovative Protein Therapeutics for Inflammatory Indications

Sofinnova Partners appoints Dr. Martin T. Rothman as Venture Partner

Highlife appoints Dr. Martin Rothman as independent member of the board

Shockwave Launches Coronary Intravascular Lithotripsy in Europe